earnings
confidence high
sentiment positive
materiality 0.85
HCA Q4 net income $1.81B ($5.75 EPS); guides 2022 rev $60-62B; $8B buyback
HCA Healthcare, Inc.
2021-FY EPS reported
$21.16
revenue$58,752,000,000
- Revenue $15.064B, net income $1.814B (diluted EPS $5.75) vs $1.426B ($4.13) in Q4 2020.
- Adjusted EBITDA $3.149B in Q4; 2022 guidance: rev $60-62B, adj EBITDA $12.55-13.05B, EPS $18.40-19.20.
- Board authorized additional $8B share repurchase program; $586M remaining under prior authorization as of Dec 31.
- Quarterly dividend declared at $0.56 per share, payable March 31, 2022.
- Andrea B. Smith appointed independent director, increasing board to 11; serves on audit and patient safety committees.